# Alnylam Pharmaceuticals Inc. – FDA Inspection, May 4, 2018

Source: https://www.keypedia.com/records/fda_inspections/alnylam-pharmaceuticals-inc/1691a345-79e1-4df1-8ec0-180e5d67002c
Source feed: FDA_Inspections

> FDA inspection 1050730 of Alnylam Pharmaceuticals Inc., May 04, 2018. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 211. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1050730
- Company Name: Alnylam Pharmaceuticals Inc.
- Inspection Date: 2018-05-04
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: New Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New England District Office
- Citation Count: 4

## Related Documents

- [FDA Inspection 1262276 - 2025-02-25](https://www.keypedia.com/records/fda_inspections/alnylam-pharmaceuticals-inc/f171eb1e-7893-4b06-a4b1-a428da24972b)
- FDA Inspection 1109687 - 2019-09-13

## Related Officers

- Issuing Officer
- [FDA Associated Person](https://www.keypedia.com/people/sean-r-marcsisin/45c910a9-9019-4419-9af8-b1c9f3b1e976)

Company: https://www.keypedia.com/companies/alnylam-pharmaceuticals-inc/285be436-d642-438b-ac4c-530088c678b8

Office: https://www.keypedia.com/offices/new-england-district-office/aa458072-2f1d-4231-89f5-21ba7a3b7144